FX1
Product Specifications
UNSPSC Description
FX1 is a potent and specific BCL6 inhibitor, with an IC50 of around 35 μM.
Target Antigen
Apoptosis; Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FX1.html
Purity
98.0
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C(O)CCN(C/1=O)C(SC1=C2C(NC3=C/2C=C(Cl)C=C3)=O)=S
Molecular Weight
368.82
References & Citations
[1]Mariano G et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep 1; 126(9): 3351–3362.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-102027/FX1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-102027/FX1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1426138-42-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC224339L3 10 µg
Aspartate beta hydroxylase (ASPH) (NM_020164) Human Tagged Lenti ORF Clone
Ask
View Details 